According to reports, the use of quercetin-PLG with polymeric nanoparticles in the treatment of liver cancer resulted in effects such as reduced release of cytochrome C from mitochondria, cytosolic SOD, increased glutathione-one-D-transferase, and inhibition of lipid peroxidation leading to cell cycle arrest. This evidence concerns the gene CYCS and liver cancer.